VIR BIOTECHNOLOGY, INC. (VIR): Price and Financial Metrics

VIR BIOTECHNOLOGY, INC. (VIR): $8.95

0.23 (-2.51%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add VIR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#143 of 352

in industry

VIR Price/Volume Stats

Current price $8.95 52-week high $25.37
Prev. close $9.18 52-week low $7.61
Day low $8.91 Volume 1,017,910
Day high $9.15 Avg. volume 1,071,356
50-day MA $9.66 Dividend yield N/A
200-day MA $9.71 Market Cap 1.22B

VIR Stock Price Chart Interactive Chart >


VIR BIOTECHNOLOGY, INC. (VIR) Company Bio


Vir Biotechnology, Inc. engages in the provision of technologies to treat and prevent infectious diseases. Its technology platforms include antibody, T cell, innate immunity, and siRNA.


VIR Latest News Stream


Event/Time News Detail
Loading, please wait...

VIR Latest Social Stream


Loading social stream, please wait...

View Full VIR Social Stream

Latest VIR News From Around the Web

Below are the latest news stories about VIR BIOTECHNOLOGY INC that investors may wish to consider to help them evaluate VIR as an investment opportunity.

I See a Good Trade on a $10 Biotech Stock

Small biotech Vir Biotechnology, Inc. took a bit of a dump lower in July when its mid-stage flu candidate posted disappointing trial results. This is because as of the end of the third quarter, VIR Biotechnology had net cash of $1.7 billion. This means an investor is essentially getting VIR's assets for free and this can be mitigated even further via a covered call strategy.

Yahoo | December 17, 2023

Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation

SAN FRANCISCO, December 13, 2023--Vir Biotechnology makes strategic changes to focus capital allocation on programs with the highest potential for patient impact and value creation.

Yahoo | December 13, 2023

Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference

SAN FRANCISCO, December 06, 2023--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Vir’s Chief Executive Officer, will present at the J.P. Morgan 2024 42nd Annual Healthcare Conference on Wednesday, January 10, at 3:45 p.m. PT / 6:45 p.m. ET.

Yahoo | December 6, 2023

7 Small-Cap Stocks to Buy BEFORE the Year-End Rally

explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy

Muslim Farooque on InvestorPlace | November 30, 2023

Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023

SAN FRANCISCO, November 13, 2023--Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023

Yahoo | November 13, 2023

Read More 'VIR' Stories Here

VIR Price Returns

1-mo -8.02%
3-mo -12.00%
6-mo -9.50%
1-year N/A
3-year -80.61%
5-year N/A
YTD -11.03%
2023 -60.25%
2022 -39.55%
2021 56.35%
2020 112.96%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!